WIGS: The Water Drinking Test in Glaucoma Study

Sponsor
Imperial College London (Other)
Overall Status
Recruiting
CT.gov ID
NCT05283031
Collaborator
(none)
40
1
18.6
2.1

Study Details

Study Description

Brief Summary

To investigate the correlation and agreement between the intraocular pressure peaks detected during the water drinking test and modified diurnal tension curve in glaucomatous eyes and to analyse whether this is associated with prognostic outcome. The study will also measure autonomic nervous system activation during the test to investigate one possible mechanism behind it.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Modified Diurnal Tension Curve

Detailed Description

Glaucoma is a progressive optic neuropathy characterized by progressive loss of retinal ganglion cells, leading to thinning of the retinal nerve fiber layer and visual field losses. It is the leading cause of irreversible blindness in the world [2] and affects more than 70 million people worldwide. Intraocular pressure (IOP) is the main risk factor for the development and progression of glaucoma. The gold standard for intraocular pressure (IOP) measurement is applanation tonometry. Routine office measurements may not detect IOP peaks in roughly 30% of patients due to variation throughout the day and this detection failure may be responsible for visual field progression in apparently well-controlled patients. Therefore this study is to investigate the correlation and agreement between the intraocular pressure peaks detected during the water drinking test and modified diurnal tension curve in glaucomatous eyes and to analyze whether this is associated with prognostic outcome. The study will also measure autonomic nervous system activation during the test to investigate one possible mechanism behind it. The primary measure is peak Intraocular pressure measurements from two different measures. Secondary measures include OCT angiography, postural blood pressure, heart rate, pupil diameter. Current and future rates of progression using visual field and optical coherence tomography (OCT) measures. This is a prospective method comparison study, of 40 primary open angle and normal tension glaucoma patients who will attend for a single visit. Inclusion criteria include those

  • Able to give informed consent to participate in the study

  • Aged between 40 and 80 years of age

  • Clear optical media

  • Spherical equivalent +-10 Dioptres

  • Normal tension glaucoma proven by visual field testing or OCT imaging combined with clinical assessment.

  • Primary open angle glaucoma proven by visual field testing or OCT imaging combined with clinical assessment

Following completion of the study, participants will be followed up in their usual clinic as part of their regular care. The participants' follow-up data which is routinely generated as part of the glaucoma care pathway will be accessed for 18 months following completion of participation with a view of correlating initial results with possible disease progression and other related outcomes.

Study Design

Study Type:
Observational
Anticipated Enrollment :
40 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Water Drinking Test in Glaucoma Study
Actual Study Start Date :
Mar 12, 2021
Anticipated Primary Completion Date :
Sep 30, 2022
Anticipated Study Completion Date :
Sep 30, 2022

Outcome Measures

Primary Outcome Measures

  1. Peak Intraocular Pressure measurements from the two different methods [Baseline assessment on one day during office hours]

    The modified diurnal tension curve is a test that consists of four to five eye pressure measurements taken through out office hours to check for rises in pressure that may be missed during their clinic appointment.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Able to give informed consent to participate in the study

  • Aged between 40 and 80 years of age

  • Clear optical media

  • Spherical equivalent +-10 Dioptres

  • Normal tension glaucoma proven by visual field testing or OCT imaging combined with clinical assessment.

  • Primary open angle glaucoma proven by visual field testing or OCT imaging combined with clinical assessment.

Exclusion Criteria:
  • Are using ocular hypotensive therapy, or have done so in the last 30 days

  • Have any other known ocular disease (except glaucoma)

  • Have serious cardiac or kidney disease (WDT contra-indication)

  • Have swallowing difficulties associated with either a neurological or gastrointestinal condition.

  • Patients with any contra-indication of drinking large amounts of water in a small period of time e.g. swallowing impairment, oesophageal stricture, gastric banding.

  • Have secondary or narrow/closed angle glaucoma

  • Patients submitted to any surgical procedure or laser intervention during the evaluation period

Contacts and Locations

Locations

Site City State Country Postal Code
1 Imperial College Ophthalmic Research Group London United Kingdom NW1 5QH

Sponsors and Collaborators

  • Imperial College London

Investigators

  • Study Chair: Francesca Cordeiro, Imperial College Healthcare NHS Trust

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Imperial College London
ClinicalTrials.gov Identifier:
NCT05283031
Other Study ID Numbers:
  • 19IC5525
First Posted:
Mar 16, 2022
Last Update Posted:
Mar 16, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Imperial College London
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 16, 2022